PAA
Peregrine Asset Advisers’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,392
| Closed | -$227K | – | 189 |
|
|
2024
Q1 | $227K | Sell |
2,392
-38
| -2% | -$3.61K | 0.09% | 153 |
|
|
2023
Q4 | $217K | Buy |
+2,430
| New | +$217K | 0.11% | 148 |
|
|
2022
Q2 | – | Sell |
-12,227
| Closed | -$1.1M | – | 128 |
|
|
2022
Q1 | $1.1M | Buy |
+12,227
| New | +$1.1M | 0.56% | 46 |
|
|
2021
Q4 | – | Sell |
-4,784
| Closed | -$601K | – | 158 |
|
|
2021
Q3 | $601K | Buy |
+4,784
| New | +$601K | 0.31% | 64 |
|